Qualification of Drivers; Exemption Applications; Epilepsy and Seizure Disorders; Correction, 90212 [2024-26388]
Download as PDF
90212
Federal Register / Vol. 89, No. 220 / Thursday, November 14, 2024 / Notices
the survey as a performance
measurement tool.
Respondents: 495,972 applicants
(from January 1, 2021, to December 31,
2023) had the opportunity to complete
a survey. This gives us a 3-year average
of 165,324 applicants per year. We
estimate that it takes 3 minutes to
complete one survey. Our data indicates
that 11.14% of applicants (18,424
averaged for 3 years) completed surveys
during this timeframe.
Frequency: On occasion/as interested.
Estimated Average Burden per
Response: Three (3) minutes per person.
Estimated Total Annual Burden:
18,424 respondents × 0.05 (3/60) = 921.
Issued in New Cumberland, PA on
November 6, 2024.
Erik L. Chuba,
IT Project Manager, Office of Information and
Technology (AIT), Enterprise Program
Management Services (EPMS), AEM–320,
Business Management Portfolio, Branch B.
[FR Doc. 2024–26386 Filed 11–13–24; 8:45 am]
BILLING CODE 4910–13–P
DEPARTMENT OF TRANSPORTATION
Federal Motor Carrier Safety
Administration
[Docket No. FMCSA–2013–0442]
Qualification of Drivers; Exemption
Applications; Epilepsy and Seizure
Disorders; Correction
Federal Motor Carrier Safety
Administration (FMCSA), Department
of Transportation (DOT).
ACTION: Notice of correction; reopening
of comment period.
AGENCY:
FMCSA corrects its August 7,
2024, notice requesting comments on its
decision to renew exemptions for seven
individuals from the requirement in the
Federal Motor Carrier Safety
Regulations (FMCSRs) that interstate
commercial motor vehicle (CMV)
drivers have ‘‘no established medical
history or clinical diagnosis of epilepsy
or any other condition which is likely
to cause loss of consciousness or any
loss of ability to control a CMV’’ to
correctly list the docket number that one
individual was included in. The
exemptions enable these individuals
who have had one or more seizures and
are taking anti-seizure medication to
continue to operate CMVs in interstate
commerce. The Agency also reopens the
public comment period for that notice.
DATES: The comment period for the
notice published August 7, 2024, at 89
FR 64532, is reopened. Comments must
be received on or before December 16,
2024.
ddrumheller on DSK120RN23PROD with NOTICES1
SUMMARY:
VerDate Sep<11>2014
20:16 Nov 13, 2024
Jkt 265001
Ms.
Christine A. Hydock, Chief, Medical
Programs Division, FMCSA, DOT, 1200
New Jersey Avenue SE, Room W64–224,
Washington, DC 20590–0001, (202) 366–
4001, fmcsamedical@dot.gov. Office
hours are from 8:30 a.m. to 5 p.m. ET
Monday through Friday, except Federal
holidays. If you have questions
regarding viewing materials in the
docket, contact Dockets Operations,
(202) 366–9826.
SUPPLEMENTARY INFORMATION: On August
7, 2024, FMCSA published a notice of
renewal of exemptions (89 FR 64532),
which FMCSA announced its decision
to renew exemptions for seven
individuals from the requirement in the
Federal Motor Carrier Safety
Regulations (FMCSRs) that interstate
commercial motor vehicle (CMV)
drivers have ‘‘no established medical
history or clinical diagnosis of epilepsy
or any other condition which is likely
to cause loss of consciousness or any
loss of ability to control a CMV.’’ The
notice inadvertently published the
incorrect docket number for the renewal
applicant, Raymond Lobo (NJ). Through
this notice, FMCSA corrects the August
7, 2024, notice of renewal of exemptions
by correctly indicating the complete
docket number.1
In FR Doc. 2024–17422, starting on
page 64532 in the Federal Register of
August 7, 2024, ‘‘FMCSA–2013–044’’ is
corrected to read ‘‘FMCSA–2013–0442’’
wherever it appears in the document.
FMCSA corrects the notice and
reopens the comment period to ensure
that interested parties have sufficient
time to review and comment on the
renewal of exemptions.
FOR FURTHER INFORMATION CONTACT:
Larry W. Minor,
Associate Administrator for Policy.
[FR Doc. 2024–26388 Filed 11–13–24; 8:45 am]
BILLING CODE 4910–EX–P
DEPARTMENT OF TRANSPORTATION
Federal Transit Administration
[Docket No. FTA–2024–0009]
Notice of Buy America Waiver for
Turnout Switch Components for
Detroit People Mover
Department of Transportation
(DOT), Federal Transit Administration
(FTA).
ACTION: Notice of Buy America waiver.
AGENCY:
This notice provides
information regarding FTA’s finding
SUMMARY:
1 The published version of the original notice is
included in the docket for this correction.
PO 00000
Frm 00266
Fmt 4703
Sfmt 4703
that it is appropriate to grant a Buy
America nonavailability waiver to the
Detroit Transportation Corporation
(DTC) for the procurement of special
trackwork turnout switch components
needed for the DTC’s People Mover that
are not manufactured in the United
States. Specifically, this waiver covers
one pair of EN60E1A1 switch point rails
and all appurtenances associated with
its installation.
DATES: The waiver is applicable
November 14, 2024.
FOR FURTHER INFORMATION CONTACT:
Jason Luebbers, FTA Attorney-Advisor,
at (202) 366–8864 or Jason.Luebbers@
dot.gov.
SUPPLEMENTARY INFORMATION:
Background
With certain exceptions, FTA’s Buy
America requirements prevent FTA
from obligating an amount that may be
appropriated to carry out its program for
a project unless ‘‘the steel, iron, and
manufactured goods used in the project
are produced in the United States.’’ 49
U.S.C. 5323(j)(1). A manufactured
product is considered produced in the
United States if (1) all of the
manufacturing processes for the product
take place in the United States and (2)
all of the components of the product are
of U.S. origin. A component is
considered of U.S. origin if it is
manufactured in the United States,
regardless of the origin of its
subcomponents. 49 CFR 661.5(d).
FTA may waive Buy America
requirements for a product if, among
other reasons, a compliant version of the
product is not produced in a sufficient
and reasonably available amount or is
not of satisfactory quality. 49 U.S.C.
5323(j)(2)(B). FTA cannot deny a request
for a nonavailability waiver unless it
can provide the waiver applicant with a
written certification that the item is
produced in the United States in a
sufficient and reasonably available
amount; the item produced in the
United States is of a satisfactory quality;
and includes a list of known
manufacturers in the United States from
which the item can be obtained. 49
U.S.C. 5323(j)(6).
DTC is the owner and operator of the
Detroit People Mover, which is the
largest municipal rail system in
Michigan. It is an automated light rail
system that operates twelve rail cars on
an elevated single track in a 2.9-mile
loop with thirteen passenger stations in
Detroit’s central business district.
The existing switches were installed
as original equipment in 1987 and
designed to European standards, using
AREMA 115RE rail throughout the
E:\FR\FM\14NON1.SGM
14NON1
Agencies
[Federal Register Volume 89, Number 220 (Thursday, November 14, 2024)]
[Notices]
[Page 90212]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-26388]
-----------------------------------------------------------------------
DEPARTMENT OF TRANSPORTATION
Federal Motor Carrier Safety Administration
[Docket No. FMCSA-2013-0442]
Qualification of Drivers; Exemption Applications; Epilepsy and
Seizure Disorders; Correction
AGENCY: Federal Motor Carrier Safety Administration (FMCSA), Department
of Transportation (DOT).
ACTION: Notice of correction; reopening of comment period.
-----------------------------------------------------------------------
SUMMARY: FMCSA corrects its August 7, 2024, notice requesting comments
on its decision to renew exemptions for seven individuals from the
requirement in the Federal Motor Carrier Safety Regulations (FMCSRs)
that interstate commercial motor vehicle (CMV) drivers have ``no
established medical history or clinical diagnosis of epilepsy or any
other condition which is likely to cause loss of consciousness or any
loss of ability to control a CMV'' to correctly list the docket number
that one individual was included in. The exemptions enable these
individuals who have had one or more seizures and are taking anti-
seizure medication to continue to operate CMVs in interstate commerce.
The Agency also reopens the public comment period for that notice.
DATES: The comment period for the notice published August 7, 2024, at
89 FR 64532, is reopened. Comments must be received on or before
December 16, 2024.
FOR FURTHER INFORMATION CONTACT: Ms. Christine A. Hydock, Chief,
Medical Programs Division, FMCSA, DOT, 1200 New Jersey Avenue SE, Room
W64-224, Washington, DC 20590-0001, (202) 366-4001,
[email protected]. Office hours are from 8:30 a.m. to 5 p.m. ET
Monday through Friday, except Federal holidays. If you have questions
regarding viewing materials in the docket, contact Dockets Operations,
(202) 366-9826.
SUPPLEMENTARY INFORMATION: On August 7, 2024, FMCSA published a notice
of renewal of exemptions (89 FR 64532), which FMCSA announced its
decision to renew exemptions for seven individuals from the requirement
in the Federal Motor Carrier Safety Regulations (FMCSRs) that
interstate commercial motor vehicle (CMV) drivers have ``no established
medical history or clinical diagnosis of epilepsy or any other
condition which is likely to cause loss of consciousness or any loss of
ability to control a CMV.'' The notice inadvertently published the
incorrect docket number for the renewal applicant, Raymond Lobo (NJ).
Through this notice, FMCSA corrects the August 7, 2024, notice of
renewal of exemptions by correctly indicating the complete docket
number.\1\
---------------------------------------------------------------------------
\1\ The published version of the original notice is included in
the docket for this correction.
---------------------------------------------------------------------------
In FR Doc. 2024-17422, starting on page 64532 in the Federal
Register of August 7, 2024, ``FMCSA-2013-044'' is corrected to read
``FMCSA-2013-0442'' wherever it appears in the document.
FMCSA corrects the notice and reopens the comment period to ensure
that interested parties have sufficient time to review and comment on
the renewal of exemptions.
Larry W. Minor,
Associate Administrator for Policy.
[FR Doc. 2024-26388 Filed 11-13-24; 8:45 am]
BILLING CODE 4910-EX-P